Economic evaluations in cutaneous leishmaniasis: a systematic review of literature 1980—2015

Authors

  • Jaiberth Antonio Cardona Arias Escuela de Microbiología, Universidad de Antioquia
  • Diana Astrid Patiño-Martinez Universidad de Antioquia
  • Liliana López Carvajal PECET

Keywords:

Leishmaniasis cutaneous, Economic evaluation in health care, Review literature as topic

Abstract

Cutaneous leishmaniasis presents high morbidity and few treatments, which have adverse effects, contraindications and high costs. The objective is to describe the economic evaluations for cutaneous leishmaniasis during 1980—2014, with a systematic review in Medline—Pubmed, Ovid—Medline, ScienceDirect, Scielo, Health Technology Assessment and NHS—Economic Evaluation Database, with ex—ante protocol with 10 search strategies, inclusion criteria, exclusion, methodological evaluation and reproducibility. 5 studios were included, 4 in America, one on costs of illness and 4 cost—effectiveness. The cost per DALY was US $ 156 in early diagnosis, US $ 1,200 in standard treatment, US $ 13,155 for vector control and US $ 15,215 for an outbreak control. The low number of economic evaluations and their relevance to the efficient allocation of resources, demonstrate the need of to increase these investigations, prioritizing those related to primary and secondary prevention because the standard treatment has lower cost—effectiveness.

Author Biography

Jaiberth Antonio Cardona Arias, Escuela de Microbiología, Universidad de Antioquia

Microbiólogo y Bioanalista, MSc Epidemiología, Docente Escuela de Microbiología Universidad de Antioquia

Published

2017-10-03

Issue

Section

Bibliographic review article